866-997-4948(US-Canada Toll Free)

Cardiovascular Monitoring and Diagnostic Devices Market (Product - ECG Systems (Resting ECG, Stress ECG), Event Monitors, Holter Monitors, Implantable Loop Recorders, ECG Management Systems) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Published By :

Transparency

Published Date : Aug 2016

Category :

Cardiovascular Devices

No. of Pages : 93 Pages

This report on the cardiovascular monitoring and diagnostic devices market analyzes the current and future scenario of the global market. Stroke, heart failure, and other prominent cardiovascular diseases are increasing the usage of cardiovascular monitoring and diagnostic devices. Rising geriatric population and unhealthy diet are the major drivers of the global cardiovascular monitoring and diagnostic devices market.

The cardiovascular monitoring and diagnostic devices market report comprises an elaborate executive summary, which includes a market snapshot that provides information about different segments of the market. It also provides information and data analysis of the global market with respect to the segments based on products and geography. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the market overview section. In addition, the section comprises Porters Five Forces Analysis to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis by geography and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global cardiovascular monitoring and diagnostic devices market.

Based on product, the market has been segmented into ECG systems, event monitors, Holter monitors, implantable loop recorders, and ECG management systems. The market segments have been analyzed based on available approved products, cost-effectiveness, and preference for technologies by physicians and patients. The market size and forecast for each of these segments have been provided for the period from 2014 to 2024, along with their respective CAGRs for the forecast period from 2016 to 2024, considering 2015 as the base year.

Geographically, the global cardiovascular monitoring and diagnostic devices market has been categorized into five major regions and the key countries in the respective region: North America (U.S. and Canada), Europe (U.K., Germany, France, and Rest of Europe), Asia Pacific (Japan, China, India, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Rest of the World. The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2013 to 2024, along with their respective CAGRs for the forecast period from 2016 to 2024, considering 2015 as the base year. The research study also covers the competitive scenario in these regions.

The report also profiles major players in the global cardiovascular monitoring and diagnostic devices market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major players profiled in this report include Boston Scientific Corporation, Fukuda Denshi Co. Ltd., GE Healthcare, Hill-Rom Holdings, Inc., Johnson & Johnson, LivaNova PLC, Medtronic plc, Nihon Kohden Corporation, Philips Healthcare, Siemens Healthcare, Spacelabs Healthcare (OSI Systems, Inc.), and St. Jude Medical, Inc., among others.

The global cardiovascular monitoring and diagnostic devices market has been segmented as follows:

Global Cardiovascular Monitoring and Diagnostic Devices Market, by Product

  • ECG Systems
  • Resting ECG
  • Stress ECG
  • Event Monitors
  • Holter Monitors
  • Implantable Loop Recorders
  • ECG Management Systems

Global Cardiovascular Monitoring and Diagnostic Devices Market, by Geography

  • North America
  • U.S.
  • Canada
  • Europe
  • U.K.
  • Germany
  • France
  • Rest of Europe
  • Asia Pacific
  • Japan
  • China
  • India
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Rest of World

Table of Contents

1. Preface
1.1. Report Description
1.2. Market Segmentation
1.3. Research Methodology

2. Executive Summary
2.1. Global Cardiovascular Monitoring and Diagnosis Devices Market Share, by Geography, 2013–2024 (US$ Mn)
2.2. Global Cardiovascular Monitoring and Diagnosis Devices Market, by Product Type, 2015 (US$ Mn)
2.3. Global Cardiovascular Monitoring and Diagnosis Devices Market, by Geography, 2015 and 2024 (Value %)
2.4. Cardiovascular Monitoring and Diagnosis Devices: Market Snapshot

3. Industry Analysis: Cardiovascular Monitoring and Diagnosis Devices Market
3.1. Industry Overview
3.2. Market Drivers
3.3. Market Restraints
3.4. Market Opportunities
3.5. Porter’s Five Forces Analysis
3.6. Market Attractiveness 
3.7. Market Positioning of Key Players, (Value %) (2015)
3.8. Recommendations 
3.9. Global Cardiovascular Monitoring and Diagnosis Devices Market Revenue, by Product Type, 2013-2024 (US$ Mn)
3.9.1. Introduction
3.9.2. ECG Systems
3.9.2.1. Resting ECG Systems
3.9.2.2. Stress ECG Systems
3.9.3. Event Monitors
3.9.4. Holter Monitors
3.9.5. Implantable Loop Recorders
3.9.6. ECG Management Systems

4. Global Cardiovascular Monitoring and Diagnosis Devices Market Share, by Geography
4.1. Introduction: Global Cardiovascular Monitoring and Diagnosis Devices Market Revenue, by Country and Product Type, 2013–2024 (US$ Mn)
4.2. North America Cardiovascular Monitoring and Diagnosis Devices Market Revenue, by Country and Product Type, 2013–2024 (US$ Mn)
4.3. Europe Cardiovascular Monitoring and Diagnosis Devices Market Revenue, by Country and Product Type, 2013–2024 (US$ Mn)
4.4. Asia Pacific Cardiovascular Monitoring and Diagnosis Devices Market Revenue, by Country and Product Type, 2013–2024 (US$ Mn)
4.5. Latin America Cardiovascular Monitoring and Diagnosis Devices Market Revenue, by Country and Product Type, 2013–2024 (US$ Mn)
4.6. Rest of World Cardiovascular Monitoring and Diagnosis Devices Market Revenue, by Country and Product Type, 2013–2024 (US$ Mn)

5. Company Profiles
5.1. Boston Scientific Corporation
5.1.1. Company Overview
5.1.2. Product Portfolio
5.1.3. Financial Overview
5.1.4. Product Portfolio
5.1.5. Recent Developments
5.2. Fukuda Denshi Co. Ltd.
5.2.1. Company Overview
5.2.2. Product Portfolio
5.2.3. Financial Overview
5.2.4. Product Portfolio
5.2.5. Recent Developments
5.3. GE Healthcare
5.3.1. Company Overview
5.3.2. Product Portfolio
5.3.3. Financial Overview
5.3.4. Product Portfolio
5.3.5. Recent Developments
5.4. Hill-Rom Holdings, Inc.
5.4.1. Company Overview
5.4.2. Product Portfolio
5.4.3. Financial Overview
5.4.4. Product Portfolio
5.4.5. Recent Developments
5.5. Johnson & Johnson
5.5.1. Company Overview
5.5.2. Product Portfolio
5.5.3. Financial Overview
5.5.4. Product Portfolio
5.5.5. Recent Developments
5.6. LivaNova PLC
5.6.1. Company Overview
5.6.2. Product Portfolio
5.6.3. Financial Overview
5.6.4. Product Portfolio
5.6.5. Recent Developments
5.7. Medtronic plc
5.7.1. Company Overview
5.7.2. Product Portfolio
5.7.3. Financial Overview
5.7.4. Product Portfolio
5.7.5. Recent Developments
5.8. Nihon Kohden Corporation
5.8.1. Company Overview
5.8.2. Product Portfolio
5.8.3. Financial Overview
5.8.4. Product Portfolio
5.8.5. Recent Developments
5.9. Philips Healthcare
5.9.1. Company Overview
5.9.2. Product Portfolio
5.9.3. Financial Overview
5.9.4. Product Portfolio Company Overview
5.9.5. Product Portfolio
5.9.6. Financial Overview
5.9.7. Product Portfolio
5.9.8. Recent Developments
5.9.9. Recent Developments
5.10. Siemens Healthcare
5.10.1. Company Overview
5.10.2. Product Portfolio
5.10.3. Financial Overview
5.10.4. Product Portfolio
5.10.5. Recent Developments
5.11. Spacelabs Healthcare (OSI Systems, Inc.)
5.11.1. Company Overview
5.11.2. Product Portfolio
5.11.3. Financial Overview
5.11.4. Product Portfolio
5.11.5. Recent Developments
5.12. St. Jude Medical, Inc.,
5.12.1. Company Overview
5.12.2. Product Portfolio
5.12.3. Financial Overview
5.12.4. Product Portfolio
5.12.5. Recent Development

List of Table

TABLE 1: Cardiovascular Monitoring and Diagnostic Devices Market Snapshot
TABLE 2: Global Cardiovascular Monitoring and Diagnostic Devices Market Revenue, by Product Type, (US$ Mn), 2013–2024
TABLE 3: Global ECG Systems Market Revenue (US$ Mn), 2013–2024
TABLE 4: Global Cardiovascular Monitoring and Diagnostic Devices Market Revenue, by Geography, (US$ Mn), 2013–2024
TABLE 5: North America Cardiovascular Monitoring and Diagnostic Devices Market Revenue, by Country (US$ Mn), 2013–2024
TABLE 6: North America Cardiovascular Monitoring and Diagnostic Devices Market Revenue, by Product Type (US$ Mn), 2013–2024
TABLE 7: Europe Cardiovascular Monitoring and Diagnostic Devices Market Revenue, by Country (US$ Mn), 2013–2024
TABLE 8: Europe Cardiovascular Monitoring and Diagnostic Devices Market Revenue, by Product Type (US$ Mn), 2013–2024
TABLE 9: Asia Pacific Cardiovascular Monitoring and Diagnostic Devices Market Revenue, by Country (US$ Mn), 2013–2024
TABLE 10: Asia Pacific Cardiovascular Monitoring and Diagnostic Devices Market Revenue, by Product Type (US$ Mn), 2013–2024
TABLE 11: Latin America Cardiovascular Monitoring and Diagnostic Devices Market Revenue, by Country (US$ Mn), 2013–2024
TABLE 12: Latin America Cardiovascular Monitoring and Diagnostic Devices Market Revenue, by Product Type (US$ Mn), 2013–2024
TABLE 13: Rest of the World Cardiovascular Monitoring and Diagnostic Devices Market Revenue, by Product Type (US$ Mn), 2013–2024

List of Chart

FIG 1. Market Segmentation
FIG 2. Global Cardiovascular Monitoring and Diagnostic Devices Market, Estimates and Forecast, by Revenue, (US$ Mn), 2013–2024
FIG 3. Global Cardiovascular Monitoring and Diagnostic Devices Market, by Product Type, (US$ Mn), 2015
FIG 4. Global Cardiovascular Monitoring and Diagnostic Devices Market, by Geography, (Value %), 2015 and 2024
FIG 5. St. Jude Medical HeartMate 3 (Left Ventricular Assist System)
FIG 6. Global Population, by Age group (%) 2000
FIG 7. Global Population, by Age group (%) 2050
FIG 8. Porter’s Five Forces Analysis: Cardiovascular Monitoring and Diagnostic Devices Market
FIG 9. Market Attractiveness Analysis - Cardiovascular Monitoring and Diagnostic Devices Market
FIG 10. Market Share of Companies, Cardiovascular Monitoring and Diagnostic Devices (%) (2015)
FIG 11. Global Resting ECG Systems Market Revenue, (US$ Mn), 2013–2024
FIG 12. Global Stress ECG Systems Market Revenue, (US$ Mn), 2013–2024
FIG 13. Global Event Monitors Market Revenue, (US$ Mn), 2013–2024
FIG 14. Global Holter Monitors Market Revenue, (US$ Mn), 2013–2024
FIG 15. Global Implantable Loop Recorders Market Revenue, (US$ Mn), 2013–2024
FIG 16. Global ECG Management Systems Market Revenue, (US$ Mn), 2013–2024
FIG 17. Rest of the World Cardiovascular Monitoring and Diagnostic Devices Market Revenue, (US$ Mn), 2013–2024
FIG 18. Boston Scientific Corporation Financial Overview (US$ Mn), 2013–2015
FIG 19. Fukuda Denshi Co., Ltd. Financial Overview (US$ Mn), 2013–2015
FIG 20. GE Healthcare Financial Overview (US$ Mn), 2013–2015
FIG 21. Hill-Rom Holdings, Inc. Financial Overview (US$ Mn), 2013–2015
FIG 22. Johnson & Johnson Financial Overview (US$ Mn), 2013–2015
FIG 23. Medtronic plc Financial Overview (US$ Mn), 2013–2015
FIG 24. Nihon Kohden Corporation Financial Overview (US$ Mn), 2013–2015
FIG 25. Philips Healthcare Financial Overview: (US$ Mn), 2013–2015
FIG 26. Siemens Healthcare Financial Overview (US$ Mn), 2013–2015
FIG 27. Spacelabs Healthcare Financial Overview (US$ Mn), 2013–2015
FIG 28. St. Jude Medical, Inc. Financial Overview (US$ Mn), 2013–2015

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *

Upcoming Reports